Ranibizumab er et humaniseret rekombinant monoklonalt antistoffragment rettet mod human vaskulær endotelial vækstfaktor A (VEGF- A).
Ranibizumab is a humanised recombinant monoclonal antibody fragment targeted against human vascular endothelial growth factor A (VEGF-A).